Literature DB >> 10907029

[Hypercoagulation in patients with nephrotic syndrome].

Z Zdrojewski1, A Raszeja-Specht, A Skibowska, A Owczarzak, B Rutkowski.   

Abstract

Hypercoagulation and thrombotic complications associated with nephrotic syndrome (NS) are known from many years. However pathomechanism of those disturbances is not very clear. The aim of the presented study was to determine the role of platelets in hypercoagulation phenomenon in NS patients. Studies were carried out in 15 patients with NS in the course of chronic glomerulonephritis and 15 healthy volunteers. Following parameters were estimated: prothrombin, time APTT, fibrinogen, FDP, plasminogen, antithrombin III, alpha 2-antiplasmin and using Technicon H1 autoanalyser: platelet count (PLT), mean platelet volume (MPV) and PLT Mode. Additionally platelets aggregation (spontaneous and after collagen, epinephrine, ADP) was measured using Apact (Labor) aggregometer. We observed in patients with NS: a) decrease of AT III, b) slight increase (not significant) of fibrinogen, c) decrease of MPV and Mode PLT, d) increased spontaneous aggregation and sensitivity to aggregating agents. Our results suggest that: 1. Pathomechanism of hypercoagulation in NS is multifactorial. 2. Changes in morphology and function of platelets could be one of the factor playing important role in this mechanism.

Entities:  

Mesh:

Year:  1997        PMID: 10907029

Source DB:  PubMed          Journal:  Pol Merkur Lekarski        ISSN: 1426-9686


  2 in total

1.  Platelet-derived growth factor and platelet profiles in childhood nephrotic syndrome.

Authors:  Anna M Wasilewska; Walentyna M Zoch-Zwierz; Barbara Tomaszewska; Anna Biernacka
Journal:  Pediatr Nephrol       Date:  2004-10-13       Impact factor: 3.714

2.  A case of membranous glomerulonephritis presenting as pulmonary embolism and acute hyperlipidaemia.

Authors:  A J Hartland; P D Giles; J E Bridger; W Simmons
Journal:  J Clin Pathol       Date:  2002-07       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.